ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) FCF Margin % : 72.05% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ExpreS2ion Biotech Holding AB's Free Cash Flow for the three months ended in Mar. 2024 was kr0.67 Mil. ExpreS2ion Biotech Holding AB's Revenue for the three months ended in Mar. 2024 was kr0.92 Mil. Therefore, ExpreS2ion Biotech Holding AB's FCF Margin % for the quarter that ended in Mar. 2024 was 72.05%.

As of today, ExpreS2ion Biotech Holding AB's current FCF Yield % is -87.31%.

The historical rank and industry rank for ExpreS2ion Biotech Holding AB's FCF Margin % or its related term are showing as below:

OSTO:EXPRS2' s FCF Margin % Range Over the Past 10 Years
Min: -1966.12 Med: -264.42 Max: -89.98
Current: -1137.14

During the past 11 years, the highest FCF Margin % of ExpreS2ion Biotech Holding AB was -89.98%. The lowest was -1966.12%. And the median was -264.42%.

OSTO:EXPRS2's FCF Margin % is ranked worse than
77.51% of 1045 companies
in the Biotechnology industry
Industry Median: -139.31 vs OSTO:EXPRS2: -1137.14

ExpreS2ion Biotech Holding AB FCF Margin % Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB FCF Margin % Chart

ExpreS2ion Biotech Holding AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-114.35

-362.43

-378.95

-1,966.12

-1,459.60

ExpreS2ion Biotech Holding AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-1,588.15	-1,814.32	-846.08	-1,352.12	72.05

Competitive Comparison of ExpreS2ion Biotech Holding AB's FCF Margin %

For the Biotechnology subindustry, ExpreS2ion Biotech Holding AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ExpreS2ion Biotech Holding AB's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ExpreS2ion Biotech Holding AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ExpreS2ion Biotech Holding AB's FCF Margin % falls into.

ExpreS2ion Biotech Holding AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ExpreS2ion Biotech Holding AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-102.902	/	7.05
	=	-1,459.60 %

ExpreS2ion Biotech Holding AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0.665	/	0.923
	=	72.05 %

ExpreS2ion Biotech Holding AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

5JD:Germany

Address

c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25

Website

https://www.expres2ionbio.com

ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines